229 related articles for article (PubMed ID: 17397295)
1. Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogs.
Borgatti-Jeffreys A; Hooser SB; Miller MA; Lucroy MD
Am J Vet Res; 2007 Apr; 68(4):399-404. PubMed ID: 17397295
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
Frimberger AE; Moore AS; Cincotta L; Cotter SM; Foley JW
Clin Cancer Res; 1998 Sep; 4(9):2207-18. PubMed ID: 9748141
[TBL] [Abstract][Full Text] [Related]
4. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
Mir Y; van Lier JE; Paquette B; Houde D
Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3.
Milla LN; Yslas EI; Cabral A; Durantini EN; Romanini S; Rivarola V; Bertuzzi M
Biomed Pharmacother; 2009 Mar; 63(3):209-15. PubMed ID: 18599256
[TBL] [Abstract][Full Text] [Related]
6. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
[TBL] [Abstract][Full Text] [Related]
7. Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in beagle dogs.
Liu W; Chen N; Jin H; Huang J; Wei J; Bao J; Li C; Liu Y; Li X; Wang A
Regul Toxicol Pharmacol; 2007 Apr; 47(3):221-31. PubMed ID: 17367655
[TBL] [Abstract][Full Text] [Related]
8. Localization and phototoxic effect of zinc sulfophthalocyanine photosensitizer in human colon (DLD-1) and lung (A549) carcinoma cells (in vitro).
Manoto SL; Sekhejane PR; Houreld NN; Abrahamse H
Photodiagnosis Photodyn Ther; 2012 Mar; 9(1):52-9. PubMed ID: 22369729
[TBL] [Abstract][Full Text] [Related]
9. [Effect of zinc phthalocyanine-mediated photodynamic therapy on bone marrow purging, an experimental study].
Huang HF; Chen YZ; Wu Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):986-91. PubMed ID: 12899802
[TBL] [Abstract][Full Text] [Related]
10. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis.
Fabris C; Valduga G; Miotto G; Borsetto L; Jori G; Garbisa S; Reddi E
Cancer Res; 2001 Oct; 61(20):7495-500. PubMed ID: 11606385
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats.
Peaston AE; Leach MW; Higgins RJ
J Am Vet Med Assoc; 1993 Apr; 202(8):1261-5. PubMed ID: 8496082
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
Reddan JC; Anderson CY; Xu H; Hrabovsky S; Freye K; Fairchild R; Tubesing KA; Elmets CA
Photochem Photobiol; 1999 Jul; 70(1):72-7. PubMed ID: 10420845
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic effects of ZnPcS(4)-BSA in human retinal pigment epithelium cells.
Huang Y; Xu G; Peng Y; Chen S; Wu Y
J Ocul Pharmacol Ther; 2009 Jun; 25(3):231-8. PubMed ID: 19456258
[TBL] [Abstract][Full Text] [Related]
14. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.
Bremner JC; Wood SR; Bradley JK; Griffiths J; Adams GE; Brown SB
Br J Cancer; 1999 Oct; 81(4):616-21. PubMed ID: 10574246
[TBL] [Abstract][Full Text] [Related]
15. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.
Camerin M; Magaraggia M; Soncin M; Jori G; Moreno M; Chambrier I; Cook MJ; Russell DA
Eur J Cancer; 2010 Jul; 46(10):1910-8. PubMed ID: 20356732
[TBL] [Abstract][Full Text] [Related]
16. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
Mosa M; Zitko M; Poucková P
Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of photodynamic treatment using aluminum phthalocyanine tetrasulfonate chloride as a photosensitizer: new approach.
Amin RM; Hauser C; Kinzler I; Rueck A; Scalfi-Happ C
Photochem Photobiol Sci; 2012 Jul; 11(7):1156-63. PubMed ID: 22402592
[TBL] [Abstract][Full Text] [Related]
18. Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy.
Vittar NB; Prucca CG; Strassert C; Awruch J; Rivarola VA
Int J Biochem Cell Biol; 2008; 40(10):2192-205. PubMed ID: 18440266
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report.
Tanabe S; Yamaguchi M; Iijima M; Nakajima S; Sakata I; Miyaki S; Takemura T; Furuoka H; Kobayashi Y; Matsui T; Uzuka Y; Sarashina T
Vet J; 2004 May; 167(3):286-93. PubMed ID: 15080878
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with aluminum-chloro-phthalocyanine induces necrosis and vascular damage in mice tongue tumors.
Longo JP; Lozzi SP; Simioni AR; Morais PC; Tedesco AC; Azevedo RB
J Photochem Photobiol B; 2009 Feb; 94(2):143-6. PubMed ID: 19097802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]